|
|
 |
To view the biographies click on the names of the directors below.
-
-
-
 |
|
|
Close |
| |
Giovanni Recordati holds a Ph.D. in chemical engineering from the Politecnico di Milano and a master's degree in management science from the Imperial College, University of London.
He joined Recordati in 1974. In 1980 he was named vice president for manufacturing and in 1984 he added responsibility for research & development and corporate operations. In 1990 he became president and chief operating officer. Since 1977 he has been a member of the Board of Directors.
Presently he is chairman and chief executive officer of the Recordati group.
|
-
-
 |
|
|
Close |
| |
Alberto Recordati earned a degree in biochemistry from King's College of the University of London in 1977. In 1984 he earned a Ph.D. in biochemistry at the Charing Cross Hospital Medical School of the same university.
He joined Recordati in 1984 as researcher in the biochemistry and immunology lab. In 1987 he was in charge of the planning and product development unit. From 1990 to 1992 he worked at Pharmetrix Corp., a United States subsidiary, as research coordinator. In 1992 he was appointed industrial manager for biochemicals, in charge of biochemical/microbiological research and the biochemical/fermentation production. In 1995 he became general manager of the chemicals research and technologies division, and in 1999 President of the pharmaceutical chemicals division. In 2004 he was appointed Vice Chairman of the Board.
|
-
-
 |
|
|
Close |
| |
Walter Bevilacqua holds a Dr Ing degree in engineering from the Politecnico di Milano and an MBA from the Harvard Business School. After a short academic experience he pursued a career in management in the chemical and pharmaceutical industry holding financial and marketing positions, including heading the pharmaceuticals division of Recordati (1981). He then joined Olivetti (1986), heading a US subsidiary and later a group of software and information services companies. He has been with Recordati again since 1996.
|
-
-
 |
|
|
Close |
| |
Luciano Bonacorsi earned a law degree from the
Università degli Studi di Milano in 1981.
He began his career at S.I.P. (now Telecom Italia), where he was
hired as assistant to the district human resources director in
1982. From 1987 to 1989 he was assistant to the labour relations
director at Federchimica. In 1989 he moved to Esselunga as human
resources manager, first regionally and then at headquarters. He
joined Recordati in 1994, where he was put in charge of labour
relations and plant human resources. After a brief hiatus as
director of personnel and general affairs at Valeas Industria
Farmaceutica, he returned to Recordati where he has been
vice-president and director human resources since 1997.
|
-
-
 |
|
|
Close |
| |
Celestino Di Rollo holds a degree in business science with a major
in marketing from the Politecnico of Business Studies in
Lugano.
He began his career in 1987 as medical representative in Simes, a
Zambon Group company.
From 1999 to 2002 he hold positions with increasing
responsibilities becoming sales manager in leading pharmaceutical
companies.
He joined the Recordati Group in 2002 as the sales manager of the
French subsidiary Laboratoires Bouchara Recordati. In 2007 he was
appointed to the position of director of marketing and sales
ethical products in Italy, subsequently became director of
pharmaceutical operations Italy and in April 2009 General Manager
Pharmaceuticals Italy.
|
-
-
 |
|
|
Close |
| |
Duccio Favara graduated in Industrial Chemistry at the
Università degli Studi di Milano. In 1970 he joined as a
medicinal chemist Gruppo Lepetit where he pursued a carer in
R&D including a one-year stage at the New England Laboratories
of the Dow Chemical Company in the United States. In 1982 he moved
to Pierrel, an Italian pharmaceutical company, initially as a team
leader, from 1986 as R&D Director for synthesis, analysis
and pharmaceutical technology and from 1989 as licensing manager.
He joined Recordati as senior licensing manager in 1993 and during
1997-2004 his activity was carried out at the Swiss affiliate of
Recordati. Since 2008 he heads the licensing group at Recordati.
|
-
-
 |
|
|
Close |
| |
Safuan Gritli holds a degree in Medicine and began his
international career exporting medical devices, followed by an
experience in the chemical sector and shortly after became involved
in the pharmaceutical business. He joined Chiesi Farmaceutici in
1988 where he held various sales and marketing positions,
contributed to the international growth of the group, participated
in a number of acquisition and international licensing activities,
and conducted the start up of new subsidiaries and the development
of the business in emerging markets. In 2001 he was appointed
Director of International Market Development and held this position
until he joined Recordati in 2008 as Vice President Corporate
Pharmaceutical Operations with the assignment to develop the
international and strategic marketing activities and to strengthen
the business in new high growth pharmaceutical markets.
|
-
-
 |
|
|
Close |
| |
Amedeo Leonardi joined Recordati in 1968 as a chemist assigned
to the laboratory of pharmaceutical chemical synthesis.
He subsequently obtained a degree in Pharmacy from the
Università degli Studi di Milano and became head of chemical
research for the group in 1983. In 1991 he became head of
pharmaceutical research which comprised the chemical and
pharmacological teams.
In 2008 he was appointed Director of Drug Discovery, following a
reorganization of the R&D function, and assumed further
scientific responsibility.
He had an active role in a number of NCE research projects
resulting in molecules active for various pharmaceutical
indications currently marketed by the group (fenticonazole and
lercanidipine), as well as in those which did not reach the
market.
He is author or co-author of 105 scientific papers, 80 posters or
oral presentations, and around 50 patents.
|
-
-
 |
|
|
Close |
| |
Diego Provvedini obtained the Medical Degree in 1978 from the
University of Parma, Italy, where he initiated his career as
Clinical Research Assistant in the Dept. of Gerontology &
Geriatrics. In order to pursue his scientific work on the endocrine
control of bone metabolism, in 1982 he joined the Dept. of Medicine
of the University of California in San Diego, where he held
university positions in the research track. After having obtained
several support grants from the U.S. National Institutes of Health
(NIH), in 1987 he continued his scientific career as Senior
Researcher in the Dept. of Immunology of the Scripps Research
Institute, in La Jolla. After moving to France in 1994, he joined
the pharmaceutical industry, first as International Project
Coordinator at the Institut de Recherches Internationales Servier,
then in 1999 as International Project Leader at Negma Laboratoires,
and in 2003 as Head of Development Strategy at Steba
Biotech-France. In 2008 he was appointed Director of Drug
Development at Recordati.
|
-
-
 |
|
|
Close |
| |
Andrea Recordati holds a Bachelor of Arts in modern and medieval
history from the Royal Holloway and Bedford New College of the
University of London.
From September 1995 to March 1998 he took part in the Smithkline
Beecham Management Access Program of in the United Kingdom becoming
project manager in charge of the development and the implementation
of an innovative marketing initiative.
He joined Recordati in 1998 as project leader for a
program directed at the improvement of field force productivity and
marketing investments optimization.
Since 1998 he has been member of the Board of Directors.
In 1999 he became manager of pharmaceutical business development
reporting to the general manager of the pharmaceutical
division.
In March 2002 he was appointed head of the newly constituted
lercanidipine business unit.
In 2008 he became director for the Western European
subsidiaries.
|
-
-
 |
|
|
Close |
| |
After obtaining a degree in medicine Arnaldo Restelli began
his career in the pharmaceutical industry (Simes, Recordati,
Lusofarmaco) holding positions with increasing responsibilities. In
2001 he joined Menarini as medical-marketing director of the
international division with responsibility for the marketing and
medical operations and field force coordination as well as the
coordination of the subsidiaries in Switzerland, Greece and
Portugal. In addition to the activities of the international
department, for about one year, he was general manager of Menarini
France, and afterwards of the Swiss subsidiary.
He returned to Recordati, where he has been appointed director of
international marketing and Southern European subsidiaries, in
2007.
|
-
-
 |
|
|
Close |
| |
Paolo Romagnoli holds a degree in chemistry from the
Università degli Studi di Milano.
He joined the Recordati Group in 1974 where he held positions of
increasing responsibility within the pharmaceutical chemicals
division beginning with the development of processes of organic
syntheses and achieving the position of head of pharmaceutical
chemicals marketing.
In 1988 he began his activity as a consultant specialised in
pharmaceutical chemicals. He dealt with many European and
North American companies accruing a profound management experience
: from strategic planning to business development, from market
research to research and development.
He joined the Angelini Group in 2003 as the manager of the fine
chemicals business unit and production facilities.
In 2006 he returned to International consulting offering extensive
support to many companies in the fine chemicals sector and in
particular as related to active pharmaceutical ingredients.
In May 2008 he rejoins Recordati as director of pharmaceutical
chemicals.
|
-
-
 |
|
|
Close |
| |
Roland Rutschmann, born in Switzerland, has a Degree in
Biochemistry with a Ph.D. in Immunology and an international
experience of more than 20 years in the pharmaceutical
industry. After the marketing and sales experiences in Roche
and Schering Plough, in 1998 he joined Warner Lambert where he was
Marketing Planning Manager for Central Eastern Europe and then
Director for Sales & Marketing in Switzerland. In 2000 Dr.
Rutschmann moved on to Actelion, a leading European biotechnology
company, where he covered different positions with growing
responsibilities: he was head of Strategic Marketing Europe &
General Manager Austria & Switzerland, then he became General
Manager Switzerland, Austria & EEMEA, till he was appointed
Vice President Emerging Markets & Geographical Expansion. In
2009 he joined Recordati as Vice President and Director for the
Special Care and Orphan Drugs business and was also appointed
General Manager of Orphan Europe.
|
-
| Fritz Squindo |
Chief Financial Officer. General Manager for the Coordination of Group Operations |
-
 |
|
|
Close |
| |
Fritz Squindo earned a degree in business administration from
Bocconi University in Milan. He began his career at Telettra, a
telecommunications company in the Fiat Group, where he worked in
treasury management. He then gained experience at the Italian
branch of the French pharmaceutical group Sanofi, where he was
first head of finance and later head of the management accounting
department. He joined Recordati with that title in 1992, and in
1995 was appointed Chief Financial Officer. In 2008 he was
also appointed General Manager for the Coordination of Group
Operations.
|
-
| Franco Tomasini |
Vice-President and Director Group Logistics and Manufacturing |
-
 |
|
|
Close |
| |
Franco Tomasini earned a management degree from Bocconi
University in Milan in 1975, and an MBA from Ottawa University
(Canada) in 1984.
From 1976 to 1981 he held various positions in the sales and
marketing department at the Venezuelan affiliate of Oscar Mayer. He
began his career at Recordati in 1984, where he was hired as
assistant to the chairman and chief executive officer. He then
became controller of the foreign subsidiaries, chief financial
officer of the U.S. affiliates, and vice president and director of
purchasing and logistics at the parent company. For two years he
served as chief executive officer of Fimei, the holding company of
the Recordati Group. Since 1999 he has been the Recordati group' s
vice-president and director of purchasing and logistics.
|
|
 |
|